Phase 1/2 Clinical Study of S-488410 Multipeptide Cancer Vaccine in Patients with Advanced or Recurrent Esophageal Squamous Cell Carcinoma.
Phase of Trial: Phase I/II
Latest Information Update: 12 May 2016
At a glance
- Drugs S 488410 (Primary)
- Indications Oesophageal cancer
- Focus Adverse reactions; Therapeutic Use
- 01 Apr 2015 Status changed from active, no longer recruiting to completed as per University Hospital Medical Information Network - Japan.
- 04 Apr 2012 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 07 Mar 2011 New trial record